Hepatic Cell News Volume 6.20 | Jun 3 2022

    0
    17







    2022-05-03 | HCN 6.20


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.20 – 3 June, 2022
    TOP STORY

    The Spatiotemporal Program of Zonal Liver Regeneration Following Acute Injury

    The authors used spatially resolved single-cell RNA sequencing to study the dynamics of mouse liver regeneration after acute acetaminophen intoxication.
    [Cell Stem Cell]

    AbstractGraphical Abstract
    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    PUBLICATIONSRanked by the impact factor of the journal

    Diploid Hepatocytes Drive Physiological Liver Renewal in Adult Humans

    The authors reported that diploid hepatocytes showed more than seven-fold higher annual birth rates than polyploid hepatocytes.
    [Cell Systems]

    Full ArticleGraphical Abstract

    Trans-Activation of Eotaxin-1 by Brg1 Contributes to Liver Regeneration

    The authors reported that exposure of primary murine hepatocytes to hepatocyte growth factor stimulated eotaxin expression.
    [Cell Death & Disease]

    Full Article

    DNAJC24 Is a Potential Therapeutic Target in Hepatocellular Carcinoma through Affecting Ammonia Metabolism

    The authors reported that high expression of DNAJC24 shortened survival in patients with HCC by immunohistochemical staining of 167 paired hepatocellular carcinomas and paraneoplastic tissues, as well as data from public databases.
    [Cell Death & Disease]

    Full Article

    Hepatocyte Bcl-3 Protects From Death-Receptor Mediated Apoptosis and Subsequent Acute Liver Failure

    Hepatic B cell leukemia-3 (Bcl-3) overexpression in hepatocytes protected from ALF with massive hepatocyte apoptosis induced by the anti-FAS antibody Jo2. .
    [Cell Death & Disease]

    Full Article

    USP53 Plays an Antitumor Role in Hepatocellular Carcinoma Through Deubiquitination of Cytochrome C

    The authors reported that ectopic expression of ubiquitin-specific peptidase 53 (USP53) inhibited the proliferation, migration and invasion, and induced the apoptosis of HCC cells.
    [Oncogenesis]

    Full Article

    Hepatocyte-Derived MANF Mitigates Ethanol-Induced Liver Steatosis in Mice via Enhancing ASS1 Activity and Activating AMPK Pathway

    Scientists reported that after chronic-plus-binge ethanol feeding, hepatocyte-specific mesencephalic astrocyte-derived neurotrophic factor (MANF) knockout mice displayed more severe hepatic steatosis and liver injury than wild-type control mice.
    [Acta Pharmacologica Sinica]

    Abstract

    Application of In Vitro Cultured Primary Hepatocytes To Evaluate Species Translatability and AAV Transduction Mechanisms of Action

    Scientists assessed whether in vitro recombinant adeno-associated virus (AAV) transduction assays in cultured primary hepatocytes from mice, nonhuman primates (NHP), and humans could model in vivo liver-directed AAV expression of valoctocogene roxaparvovec.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractGraphical Abstract

    In Vitro Proliferation and Long-Term Preservation of Functional Primary Rat Hepatocytes in Cell Fibers

    Scientists demonstrated the efficiency of proliferating primary rat hepatocytes in cell fibers not only as cell-based sensors to detect drugs that damage hepatic functions and hepatocellular processes but also as transplants to improve the plasma albumin concentrations of congenital analbuminemia.
    [Scientific Reports]

    Full Article

    Scientific resources to support your organoids research. Learn More!
    REVIEWS

    Organoids and Regenerative Hepatology

    Scientists discuss various historical aspects of 3D organoid culture, how it has been applied to the hepatobiliary system, and how organoid technology intersects with the emerging global field of liver regenerative medicine.
    [Hepatology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation

    Revive Therapeutics Ltd. announced that in light of the growing cases of acute hepatitis in children reported by the WHO, the company will advance its drug pipeline for inflammatory liver disorders including Bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation.
    [Revive Therapeutics Ltd.]

    Press Release

    Eureka Therapeutics and City of Hope Treat First Patient with GPC3 Targeting ARTEMIS® T Cells (ECT204) for Advanced Liver Cancer

    Eureka Therapeutics, Inc. and City of Hope announced that City of Hope treated the first patient with GPC3-positive advanced hepatocellular carcinoma, the predominant type of liver cancer, with ECT204, an experimental T cell therapy.
    [Eureka Therapeutics (EurekAlert!)]

    Press Release
    FEATURED EVENT

    Immuno US

    October 3 – 4, 2022
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Candidate – Cancer Biology

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    Postdoctoral Fellow – Cancer Immunology & Genomics

    La Jolla Institute for Immunology – La Jolla, California, United States

    PhD Candidate – Cellular and Molecular Mechanisms of Cancer

    Norwegian University of Science and Technology -Trondheim, Norway

    Staff Scientist – Obesity and Metabolic Diseases

    National Institutes of Health – Bethesda, Maryland, United States

    Postdoctoral Position – Lung and Liver Cancers

    Memorial Sloan Kettering Cancer Center – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter